.JPG?#)
Roche Q1 earnings: CEO warns that tariffs could impact dealmaking
Roche said that its future dealmaking could be impacted by potential tariffs on pharmaceuticals. “If there are questions around tariffs, it will be more difficult to make financial sense of any M&A deals,” the Swiss ...
Roche said that its future dealmaking could be impacted by potential tariffs on pharmaceuticals.
“If there are questions around tariffs, it will be more difficult to make financial sense of any M&A deals,” the Swiss ...
